Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00219934 · ClinicalTrials.gov registry record
Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
A clinical trial of HIV Infections, sponsored by Rockefeller University.
- Completed
- Registry status
- 399
- Enrollment target
- 1
- Study location
NCT00219934 is a study of HIV Infections that has completed, run by Rockefeller University. The registered enrollment target is 399 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00219934, a study of HIV Infections, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 399 participants
- Enrollment target
- 1
- Study location
Study Summary
Group A: Long-term follow-up is needed for subjects identified as acute or early in the course of HIV-1 infection, independent of decisions regarding therapy with highly active anti-retroviral therapy (HAART). Group B: This protocol will also be offered to subjects who were diagnosed with acute HIV-1 infection in the past and have been participating in an ADARC/Rockefeller University Hospital treatment protocol for acute HIV-1 infection, and currently have a viral load consistently less than 50 copies/ml on current treatment (Group B)
Conditions Studied
Interventions
- DRUG Antiretroviral therapy
Study Locations (1)
New York
- Rockefeller University Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2002-02 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00219934
The ClinicalTrials.gov registry entry for NCT00219934 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 399 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (10% lower). The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Antiretroviral therapy is the first listed.
NCT00219934 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00219934 about?
NCT00219934 is a clinical study titled "Observational Study of Treated and Untreated Acute and Early HIV-1 Infection". Group A: Long-term follow-up is needed for subjects identified as acute or early in the course of HIV-1 infection, independent of decisions regarding therapy with highly active anti-retroviral therapy (HAART). Group B: This protocol will also be offered to subjects who were diagnosed with acute HIV...
What is the current status of trial NCT00219934?
This trial is currently completed. The enrollment target is 399 participants. The study started on 2002-02. Estimated completion is 2010-11.
What conditions does trial NCT00219934 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00219934?
The interventions under investigation include: Antiretroviral therapy (DRUG).
Who is sponsoring clinical trial NCT00219934?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00219934 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.